Selected research
Market Analysis & Forecast
Global Medical Chatbot Market Analysis and Forecast 2026-2032
Market perspective
The global Medical Chatbot market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Medical Chatbot is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Medical Chatbot is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Medical Chatbot is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Medical Chatbot is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Medical Chatbot include OpenAI, Youper, Florence, Healthily, Ada Health, Molly, Buoy Health, Infermedica and Woebot, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Medical Chatbot, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Medical Chatbot, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Chatbot, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Medical Chatbot revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Chatbot market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Chatbot revenue, projected growth trends, production technology, application and end-user industry.
Medical Chatbot Segment by Company
OpenAI
Youper
Florence
Healthily
Ada Health
Molly
Buoy Health
Infermedica
Woebot
SmartBot360
K Health
Symptoma
Babylon Health
OneRemission
ProProfs Chat
Medical.Chat
Kore.ai
TeleVox
Hyro.ai
Doctronic
Medical Chatbot Segment by Type
For Clinician
For Patient
Others
Medical Chatbot Segment by Application
Medication Consulting
Personal Health Management
Nursing Consultation
Disease Diagnosis
Psychological Counseling
Medical Chatbot Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Chatbot market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Chatbot and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Chatbot.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Medical Chatbot in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Medical Chatbot company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Chatbot revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- For Clinician
- For Patient
- Others
Applications
- Medication Consulting
- Personal Health Management
- Nursing Consultation
- Disease Diagnosis
- Psychological Counseling
Companies covered
- OpenAI
- Youper
- Florence
- Healthily
- Ada Health
- Molly
- Buoy Health
- Infermedica
- Woebot
- SmartBot360
- K Health
- Symptoma
- Babylon Health
- OneRemission
- ProProfs Chat
- Medical.Chat
- Kore.ai
- TeleVox
- Hyro.ai
- Doctronic
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Medical Chatbot Market by Type
- 1.2.1 Global Medical Chatbot Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 For Clinician
- 1.2.3 For Patient
- 1.2.4 Others
- 1.3 Medical Chatbot Market by Application
- 1.3.1 Global Medical Chatbot Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medication Consulting
- 1.3.3 Personal Health Management
- 1.3.4 Nursing Consultation
- 1.3.5 Disease Diagnosis
- 1.3.6 Psychological Counseling
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Medical Chatbot Market Dynamics
- 2.1 Medical Chatbot Industry Trends
- 2.2 Medical Chatbot Industry Drivers
- 2.3 Medical Chatbot Industry Opportunities and Challenges
- 2.4 Medical Chatbot Industry Restraints
3 Global Growth Perspective
- 3.1 Global Medical Chatbot Market Perspective (2021-2032)
- 3.2 Global Medical Chatbot Growth Trends by Region
- 3.2.1 Global Medical Chatbot Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Medical Chatbot Market Size by Region (2021-2026)
- 3.2.3 Global Medical Chatbot Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Medical Chatbot Revenue by Players
- 4.1.1 Global Medical Chatbot Revenue by Players (2021-2026)
- 4.1.2 Global Medical Chatbot Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Medical Chatbot Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Medical Chatbot Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Medical Chatbot Key Players Headquarters & Area Served
- 4.4 Global Medical Chatbot Players, Product Type & Application
- 4.5 Global Medical Chatbot Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Medical Chatbot Market CR5 and HHI
- 4.6.3 2025 Medical Chatbot Tier 1, Tier 2, and Tier 3
5 Medical Chatbot Market Size by Type
- 5.1 Global Medical Chatbot Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Medical Chatbot Revenue by Type (2021-2032)
- 5.3 Global Medical Chatbot Revenue Market Share by Type (2021-2032)
6 Medical Chatbot Market Size by Application
- 6.1 Global Medical Chatbot Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Medical Chatbot Revenue by Application (2021-2032)
- 6.3 Global Medical Chatbot Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 OpenAI
- 7.1.1 OpenAI Company Information
- 7.1.2 OpenAI Business Overview
- 7.1.3 OpenAI Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.1.4 OpenAI Medical Chatbot Product Portfolio
- 7.1.5 OpenAI Recent Developments
- 7.2 Youper
- 7.2.1 Youper Company Information
- 7.2.2 Youper Business Overview
- 7.2.3 Youper Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.2.4 Youper Medical Chatbot Product Portfolio
- 7.2.5 Youper Recent Developments
- 7.3 Florence
- 7.3.1 Florence Company Information
- 7.3.2 Florence Business Overview
- 7.3.3 Florence Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.3.4 Florence Medical Chatbot Product Portfolio
- 7.3.5 Florence Recent Developments
- 7.4 Healthily
- 7.4.1 Healthily Company Information
- 7.4.2 Healthily Business Overview
- 7.4.3 Healthily Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.4.4 Healthily Medical Chatbot Product Portfolio
- 7.4.5 Healthily Recent Developments
- 7.5 Ada Health
- 7.5.1 Ada Health Company Information
- 7.5.2 Ada Health Business Overview
- 7.5.3 Ada Health Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.5.4 Ada Health Medical Chatbot Product Portfolio
- 7.5.5 Ada Health Recent Developments
- 7.6 Molly
- 7.6.1 Molly Company Information
- 7.6.2 Molly Business Overview
- 7.6.3 Molly Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.6.4 Molly Medical Chatbot Product Portfolio
- 7.6.5 Molly Recent Developments
- 7.7 Buoy Health
- 7.7.1 Buoy Health Company Information
- 7.7.2 Buoy Health Business Overview
- 7.7.3 Buoy Health Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.7.4 Buoy Health Medical Chatbot Product Portfolio
- 7.7.5 Buoy Health Recent Developments
- 7.8 Infermedica
- 7.8.1 Infermedica Company Information
- 7.8.2 Infermedica Business Overview
- 7.8.3 Infermedica Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.8.4 Infermedica Medical Chatbot Product Portfolio
- 7.8.5 Infermedica Recent Developments
- 7.9 Woebot
- 7.9.1 Woebot Company Information
- 7.9.2 Woebot Business Overview
- 7.9.3 Woebot Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.9.4 Woebot Medical Chatbot Product Portfolio
- 7.9.5 Woebot Recent Developments
- 7.10 SmartBot360
- 7.10.1 SmartBot360 Company Information
- 7.10.2 SmartBot360 Business Overview
- 7.10.3 SmartBot360 Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.10.4 SmartBot360 Medical Chatbot Product Portfolio
- 7.10.5 SmartBot360 Recent Developments
- 7.11 K Health
- 7.11.1 K Health Company Information
- 7.11.2 K Health Business Overview
- 7.11.3 K Health Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.11.4 K Health Medical Chatbot Product Portfolio
- 7.11.5 K Health Recent Developments
- 7.12 Symptoma
- 7.12.1 Symptoma Company Information
- 7.12.2 Symptoma Business Overview
- 7.12.3 Symptoma Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.12.4 Symptoma Medical Chatbot Product Portfolio
- 7.12.5 Symptoma Recent Developments
- 7.13 Babylon Health
- 7.13.1 Babylon Health Company Information
- 7.13.2 Babylon Health Business Overview
- 7.13.3 Babylon Health Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.13.4 Babylon Health Medical Chatbot Product Portfolio
- 7.13.5 Babylon Health Recent Developments
- 7.14 OneRemission
- 7.14.1 OneRemission Company Information
- 7.14.2 OneRemission Business Overview
- 7.14.3 OneRemission Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.14.4 OneRemission Medical Chatbot Product Portfolio
- 7.14.5 OneRemission Recent Developments
- 7.15 ProProfs Chat
- 7.15.1 ProProfs Chat Company Information
- 7.15.2 ProProfs Chat Business Overview
- 7.15.3 ProProfs Chat Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.15.4 ProProfs Chat Medical Chatbot Product Portfolio
- 7.15.5 ProProfs Chat Recent Developments
- 7.16 Medical.Chat
- 7.16.1 Medical.Chat Company Information
- 7.16.2 Medical.Chat Business Overview
- 7.16.3 Medical.Chat Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.16.4 Medical.Chat Medical Chatbot Product Portfolio
- 7.16.5 Medical.Chat Recent Developments
- 7.17 Kore.ai
- 7.17.1 Kore.ai Company Information
- 7.17.2 Kore.ai Business Overview
- 7.17.3 Kore.ai Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.17.4 Kore.ai Medical Chatbot Product Portfolio
- 7.17.5 Kore.ai Recent Developments
- 7.18 TeleVox
- 7.18.1 TeleVox Company Information
- 7.18.2 TeleVox Business Overview
- 7.18.3 TeleVox Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.18.4 TeleVox Medical Chatbot Product Portfolio
- 7.18.5 TeleVox Recent Developments
- 7.19 Hyro.ai
- 7.19.1 Hyro.ai Company Information
- 7.19.2 Hyro.ai Business Overview
- 7.19.3 Hyro.ai Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.19.4 Hyro.ai Medical Chatbot Product Portfolio
- 7.19.5 Hyro.ai Recent Developments
- 7.20 Doctronic
- 7.20.1 Doctronic Company Information
- 7.20.2 Doctronic Business Overview
- 7.20.3 Doctronic Medical Chatbot Revenue and Gross Margin (2021-2026)
- 7.20.4 Doctronic Medical Chatbot Product Portfolio
- 7.20.5 Doctronic Recent Developments
8 North America
- 8.1 North America Medical Chatbot Revenue (2021-2032)
- 8.2 North America Medical Chatbot Revenue by Type (2021-2032)
- 8.2.1 North America Medical Chatbot Revenue by Type (2021-2026)
- 8.2.2 North America Medical Chatbot Revenue by Type (2027-2032)
- 8.3 North America Medical Chatbot Revenue Share by Type (2021-2032)
- 8.4 North America Medical Chatbot Revenue by Application (2021-2032)
- 8.4.1 North America Medical Chatbot Revenue by Application (2021-2026)
- 8.4.2 North America Medical Chatbot Revenue by Application (2027-2032)
- 8.5 North America Medical Chatbot Revenue Share by Application (2021-2032)
- 8.6 North America Medical Chatbot Revenue by Country
- 8.6.1 North America Medical Chatbot Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Medical Chatbot Revenue by Country (2021-2026)
- 8.6.3 North America Medical Chatbot Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Medical Chatbot Revenue (2021-2032)
- 9.2 Europe Medical Chatbot Revenue by Type (2021-2032)
- 9.2.1 Europe Medical Chatbot Revenue by Type (2021-2026)
- 9.2.2 Europe Medical Chatbot Revenue by Type (2027-2032)
- 9.3 Europe Medical Chatbot Revenue Share by Type (2021-2032)
- 9.4 Europe Medical Chatbot Revenue by Application (2021-2032)
- 9.4.1 Europe Medical Chatbot Revenue by Application (2021-2026)
- 9.4.2 Europe Medical Chatbot Revenue by Application (2027-2032)
- 9.5 Europe Medical Chatbot Revenue Share by Application (2021-2032)
- 9.6 Europe Medical Chatbot Revenue by Country
- 9.6.1 Europe Medical Chatbot Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Medical Chatbot Revenue by Country (2021-2026)
- 9.6.3 Europe Medical Chatbot Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Medical Chatbot Revenue (2021-2032)
- 10.2 China Medical Chatbot Revenue by Type (2021-2032)
- 10.2.1 China Medical Chatbot Revenue by Type (2021-2026)
- 10.2.2 China Medical Chatbot Revenue by Type (2027-2032)
- 10.3 China Medical Chatbot Revenue Share by Type (2021-2032)
- 10.4 China Medical Chatbot Revenue by Application (2021-2032)
- 10.4.1 China Medical Chatbot Revenue by Application (2021-2026)
- 10.4.2 China Medical Chatbot Revenue by Application (2027-2032)
- 10.5 China Medical Chatbot Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Medical Chatbot Revenue (2021-2032)
- 11.2 Asia Medical Chatbot Revenue by Type (2021-2032)
- 11.2.1 Asia Medical Chatbot Revenue by Type (2021-2026)
- 11.2.2 Asia Medical Chatbot Revenue by Type (2027-2032)
- 11.3 Asia Medical Chatbot Revenue Share by Type (2021-2032)
- 11.4 Asia Medical Chatbot Revenue by Application (2021-2032)
- 11.4.1 Asia Medical Chatbot Revenue by Application (2021-2026)
- 11.4.2 Asia Medical Chatbot Revenue by Application (2027-2032)
- 11.5 Asia Medical Chatbot Revenue Share by Application (2021-2032)
- 11.6 Asia Medical Chatbot Revenue by Country
- 11.6.1 Asia Medical Chatbot Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Medical Chatbot Revenue by Country (2021-2026)
- 11.6.3 Asia Medical Chatbot Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Medical Chatbot Revenue (2021-2032)
- 12.2 SAMEA Medical Chatbot Revenue by Type (2021-2032)
- 12.2.1 SAMEA Medical Chatbot Revenue by Type (2021-2026)
- 12.2.2 SAMEA Medical Chatbot Revenue by Type (2027-2032)
- 12.3 SAMEA Medical Chatbot Revenue Share by Type (2021-2032)
- 12.4 SAMEA Medical Chatbot Revenue by Application (2021-2032)
- 12.4.1 SAMEA Medical Chatbot Revenue by Application (2021-2026)
- 12.4.2 SAMEA Medical Chatbot Revenue by Application (2027-2032)
- 12.5 SAMEA Medical Chatbot Revenue Share by Application (2021-2032)
- 12.6 SAMEA Medical Chatbot Revenue by Country
- 12.6.1 SAMEA Medical Chatbot Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Medical Chatbot Revenue by Country (2021-2026)
- 12.6.3 SAMEA Medical Chatbot Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst